EDITORIAL SECTION

Articles

The Rise of In Vivo Gene Editing: New Opportunities in Therapeutic Innovation

For most of the past decade genetic medicine has been defined by a logistical paradox The science was astonishing the operations were artisanal Cells were drawn from a patient flown to a specialist facility edited tested released and flown back for infusion after conditioning chemotherapy The results in several inherited blood disorders and aggressive cancers were among the most striking modern me...

How AI Is Addressing Drug Development Challenges in Rare Diseases?

Healthcare struggles with persistent obstacles to treat and understand rare diseases which societies call orphan diseases While affecting a minority portion of individuals these rare diseases make therapy discovery difficult because of scarce research data and expensive evaluation costs alongside multifaceted disease pathways The rising use of artificial intelligence AI drives a transformative cha...

Oral Obesity Medicines: How Pills Could Change the European GLP-1 Market

For a decade the European obesity market has been defined by a needle a fridge and a specialist clinic In July that definition broke The European Commission granted marketing authorisation for a oncedaily mg oral semaglutide tablet making it the first GLP receptor agonist

Ethical Sourcing in Pharma: Top Strategies for Sustainable Supply Chains in 2026

Pharmaceutical business is moving into a decisive decade in which ethical sourcing has ceased being a corporate value of goodwill and has become a strategic need Pharma ethical sourcing is closely connected to business continuity regulatory compliance environmental stewardship and brand trust in With supply chains that are increasingly global fragmented and vulnerable to geopolitical climatic and...

Why Biopharma is switching to Single-Use Systems: Cost, Quality, and Flexibility

Singleuse biopharma systems have replaced traditional stainlesssteel systems in the biopharmaceutical industry because of a major industry transformation What factors lead the market toward this direction Major factors that drive the industry involve establishing savings from singleuse equipment in pharmaceutical applications

The Impact of Digital Health Technologies on Patient Outcomes

It is also noteworthy that the structure of the healthcare system has shifted rather dynamically in the past few years primarily because of the integration of digital health solutions Such developments

Techno Trends

Juniper Biosciences Secures FDA Breakthrough Designation

The US Food and Drug Administration FDA has granted Breakthrough Therapy Designation to Juniper Biosciences JBS Ffluoromisonidazole or FMISO for identifying tumour hypoxia in patients with HPVpositive oropharyngeal carcinoma OPC

Projects

Onyx Scientific to Invest Over US$2 Million (£1.5 Million) in Sunderland GMP Facility Expansion

Onyx Scientific is investing more than US Million Million to expand its Good Manufacturing Practice GMP facilities at its Sunderland UK site The investment will increase capacity for commercial

Research Insights

One-month physicochemical stability study of idarubicin prepared in polyolefin-type bags for the treatment of hematological diseases

Idarubicine is a mainstay of the treatment strategy for hematological cancer The literature lacks stability data that comply with current preparation practices and recommendations for conducting stability studies

whitepaper

Post-Translational Modifications in Drug Discovery: From Molecular Regulation to Clinical Impact

For decades the central dogma of molecular biology has anchored our understanding of cellular function DNA to RNA to protein But this linear view is incomplete A growing body of evidence shows that much of biologys